1. OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study. (9th June 2015) Authors: Genovese, M.C.; Kremer, J.; Zamani, O.; Ludivico, C.; Krogulec, M.; Xie, L.; Beattie, S.; Koch, A.E.; Cardillo, T.; Rooney, T.; Macias, W.; Schlichting, D.; Smolen, J.S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (5th March 2020) Authors: Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis. (18th May 2022) Authors: Werfel, T.; Irvine, A.D.; Bangert, C.; Seneschal, J.; Grond, S.; Cardillo, T.; Brinker, D.; Zhong, J.; Riedl, E.; Wollenberg, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: 1486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. (1st August 2020) Authors: Simpson, E.L.; Lacour, J.‐P.; Spelman, L.; Galimberti, R.; Eichenfield, L.F.; Bissonnette, R.; King, B.A.; Thyssen, J.P.; Silverberg, J.I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman‐Yassky, E.; Beck, L.A.; Janes, J.M.; DeLozier, A.M.; Gamalo, M.; Brinker, D.R.; Cardillo, T. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0166 Safety Profile of Baricitinib in Patients with Active RA: An Integrated Analysis. (15th July 2016) Authors: Smolen, J.; Genovese, M.; Takeuchi, T.; Hyslop, D.; Macias, W.L.; Rooney, T.P.; Chen, L.; Dickson, C.; Riddle, J.; Cardillo, T.; Winthrop, K. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗